Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Beware the Bounce: 3 Growth Stocks to Offload Immediately

By Chris MacDonald, InvestorPlace Contributor

Investors may want to exercise caution with these three long-term growth stocks right now, especially after their recent runs.

Why META Stock’s Run Can Easily Continue Into 2024

By Chris MacDonald, InvestorPlace Contributor

Here's why growth investors may want to consider Meta Platforms as a top way to play the digital advertising and social media space in 2024.

AMD’s AI Chips Can Beat Nvidia, Buy the Stock Now

By Chris MacDonald, InvestorPlace Contributor

Here's why investors shouldn't overlook AMD stock relative to the competition, despite the company's need to make up ground.

Dividend Dynamos: 3 High-Potential Stocks for Compounding Success

By Chris MacDonald, InvestorPlace Contributor

Here are three top compounding dividend stocks long-term investors should consider including in their portfolio.

Is Safe and Green Development (SGD) Stock the Next Big Meme Stock?

By Chris MacDonald, InvestorPlace Contributor

Investors should take significant caution when a given penny stock surges, as SGD stock has over the past two days.

Truist Is Pounding the Table on Lululemon (LULU) Stock

By Chris MacDonald, InvestorPlace Contributor

Investors in LULU stock have seen very nice year-to-date gains, and the party continues today as the company receives analyst props.

Why Is Altamira Therapeutics (CYTO) Stock Up 160% Today?

By Chris MacDonald, InvestorPlace Contributor

CYTO stock shares have absolutely skyrocketed today, at one point more than tripling on heavy volume on a key bullish catalyst.

EVGO Stock Alert: EVgo Teams Up With Hertz to Offer Special Charging Rates

By Chris MacDonald, InvestorPlace Contributor

News of a partnership between EVgo and Hertz has shares of HTZ stock climbing, with EVGO shares sinking in today's session.

CHPT Stock Outlook: Is EV Player ChargePoint a Buy Heading Into 2024?

By Chris MacDonald, InvestorPlace Contributor

ChargePoint (CHPT) stock is among the EV charging shares many investors remain on the fence with, but here's why it could be intriguing.

PYPL Stock Remains an Intriguing Risk/Reward Pick Right Now. Here’s Why.

By Chris MacDonald, InvestorPlace Contributor

Here's why long-term growth investors may want to hone in on PYPL stock right now, even though it may not be the overwhelming pick.

Load More